growth hormone releasing hormone analogue
Tesamorelin clinical trials
Answer
Tesamorelin has 24 registered trials: 3 running, 14 completed, 7 stopped early. 10 posted results.
Trial registerClinicalTrials.gov, read 2026-10-03
| Trial | Title | Status | Phase | Registered | Results |
|---|---|---|---|---|---|
| NCT03226821 Trial register | Body Composition and Adipose Tissue in HIV | terminated before completion | - | 2017-07-24 | Posted |
| NCT06554717 Trial register | Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV | currently recruiting participants | - | 2024-08-15 | - |
| NCT07481734 Trial register | Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) | currently recruiting participants | - | 2026-03-19 | - |
| NCT02572323 Trial register | Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons | completed | - | 2015-10-08 | Posted |
| NCT03375788 Trial register | Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk | completed | - | 2017-12-18 | Posted |
| NCT03150511 Trial register | Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury | currently recruiting participants | - | 2017-05-12 | - |
| NCT00608023 Trial register | TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy | completed | - | 2008-02-06 | Posted |
| NCT03826160 Trial register | Growth Hormone Dynamics and Cardiac Steatosis in HIV | completed | - | 2019-01-30 | - |
| NCT01388920 Trial register | Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting | terminated before completion | - | 2011-07-07 | Posted |
| NCT02196831 Trial register | Tesamorelin Effects on Liver Fat and Histology in HIV | completed | - | 2014-07-22 | Posted |
| NCT02931474 Trial register | Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia | withdrawn before enrolling anyone | - | 2016-10-13 | - |
| NCT02553603 Trial register | The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment | completed | - | 2015-09-03 | - |
| NCT01579695 Trial register | Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® | terminated before completion | - | 2012-04-18 | - |
| NCT01591902 Trial register | Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA® | terminated before completion | - | 2012-05-04 | - |
| NCT00675506 Trial register | Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese | completed | - | 2008-05-07 | Posted |
| NCT01263717 Trial register | Effects of Growth Hormone Releasing Hormone in HIV | completed | - | 2010-12-21 | Posted |
| NCT01788462 Trial register | Egrifta Replacement and Sleep Disordered Breathing | withdrawn before enrolling anyone | - | 2013-02-11 | - |
| NCT01632592 Trial register | Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue | withdrawn before enrolling anyone | - | 2012-07-03 | - |
| NCT00795210 Trial register | Effects of Short-term Growth Hormone in HIV-infected Patients | completed | - | 2008-11-20 | Posted |
| NCT00257712 Trial register | SMART: Somatotrophics, Memory, and Aging Research Trial | completed | - | 2005-11-21 | - |
| NCT02012556 Trial register | Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients | completed | - | 2013-12-16 | - |
| NCT00123253 Trial register | TH9507 in Patients With HIV-Associated Lipodystrophy | completed | - | 2005-07-20 | - |
| NCT00850564 Trial register | Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men | completed | - | 2009-02-25 | Posted |
| NCT01264497 Trial register | Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes | completed | - | 2010-12-17 | - |
Source: ClinicalTrials.gov, read 2026-10-03. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.